市場調查報告書
商品編碼
1615880
生命科學的雲端運算IaaS的全球市場規模:各零件,各用途,部署模型,各地區,範圍及預測Global Cloud Computing IaaS In Life Science Market Size By Component, By Application, By Deployment Model, By Geographic Scope And Forecast |
2024年生命科學雲端運算IaaS市場規模為79.9億美元,預計2031年將達到768.6億美元,複合年增長率為32.70%。跨國和多州臨床試驗的激增、關鍵地區慢性病的流行以及基因療法研究正在推動生命科學領域的雲端運算 IaaS 市場。該研究報告對生命科學領域雲端運算 IaaS 的全球市場進行了全面評估。它對關鍵細分市場、趨勢、市場驅動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。
生命科學領域雲端運算 IaaS 的全球市場定義
生命科學產業依賴大量數據。因此,您需要一種有效、安全地儲存資料的方法。使資料更易於存取的有效方法是使用基於雲端的平台來儲存資料和運行軟體。這使得全球知識共享成為可能,加速這一進程,從而更快地部署疫苗、藥物以及對化學和生物系統的理解。雲端運算是一種按需提供資料儲存和處理能力的電腦系統資源。
雲端運算是一種按需提供資料儲存和處理能力的電腦系統資源,也用於定義可供許多使用者透過網際網路存取的資料伺服器。雲端運算的目的是節省資金並讓客戶專注於他們的業務目標,而不會受到 IT 問題的阻礙。基礎設施即服務(IaaS)是一種提供運算資源的雲端運算模型。基礎設施即服務 (IaaS) 與軟體即服務 (SaaS) 和平台即服務 (PaaS) 一起分類。基礎設施即服務模型透過在本地資料中心託管基礎設施元件來運作。
本地資料中心包括儲存、網路硬體等。現代社會數位化的進步正在帶動生命科學領域雲端運算IaaS市場的成長。據稱,研發疫苗需要10年時間。然而,隨著全球知識共享和雲端運算的出現,資料定位的障礙正在消失,這一步驟可能在一年內完成。此外,雲端運算可以透過更快地回應患者需求來幫助患者獲得更好的護理。
這是透過基於雲端的平台實現的,該平台提供全球數據存取以有效共享知識,從而減少觀察到的罕見案例。因此,早期介入和客製化治療可加速患者復健。雲端運算在生命科學產業中的眾多優勢之一是能夠透過將 IT 維護和支援外包給雲端供應商來最大限度地降低 IT 營運成本。這使得生命科學產業能夠將資源用於重要目標,例如開發新疫苗和藥物。
生命科學雲端運算IaaS全球市場概況
跨國和多州臨床試驗的激增、關鍵地區慢性病的流行以及基因治療研究正在推動生命科學研究的雲端運算市場。藥物開發的創新,例如個人化藥物,需要從廣泛的外部來源(包括患者、醫生和付款人)收集和分析數據。這些因素正在推動對雲端運算解決方案的需求。此外,該市場預計還將受益於合約研究組織、學術機構和醫院等各種合作夥伴進行的臨床試驗數量的大幅增加。
與內部基礎設施等傳統IT基礎設施相比,基礎設施即服務中的雲端運算也更加可靠。這些原因正在推動生命科學領域的雲端運算 IaaS 市場。然而,對透過基於雲端的模型捕獲的患者資料的安全性的重大擔憂以及缺乏對各行業隱私法規的適當遵守正在限制市場的成長。此外,由於運算解決方案針對特定需求的客製化程度不斷提高以及雲端運算中社群媒體的興起,預計採用率將會加快。此外,許多國家慢性病的流行促使公司大力投資研發,以開發新的有針對性的治療方法,為市場參與者創造了令人興奮的機會。
Cloud Computing IaaS In Life Science Market size was valued at USD 7.99 Billion in 2024 and is projected to reach USD 76.86 Billion by 2031, growing at a CAGR of 32.70% during the forecast period 2024-2031. A surge in multinational and multistate clinical trials, widespread incidence of chronic diseases in major regions, and gene therapy research are driving the market for cloud computing IaaS in life science. The Global Cloud Computing IaaS In Life Science Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cloud Computing IaaS In Life Science Market Definition
The life science industry functions on large volumes of data. As a result, it requires an efficient and secure means of storing the data. An effective way of making the data more accessible is by using cloud-based platforms for storing data and executing software. This allows processes to be accelerated because of the global knowledge-sharing created, which results in the faster rollout of vaccines, medicines, and an understanding of chemical and biological systems. Cloud computing is a computer system resource that provides data storage and processing capacity on demand.
It's also used to define data servers that are accessible over the internet to a large range of users. The goal of cloud computing is to save expenses and allow customers to focus on their business objectives rather than being blocked by IT problems. Infrastructure as a service, or IaaS, is a cloud computing model that provides computing resources. Infrastructure as a service (IaaS) is categorized along with software as a service (SaaS) and platform as a service (PaaS). The infrastructure as a service model works by hosting the infrastructure components in an on-premise data center.
The on-premise data center includes storage, networking hardware, and more. The increasing digitalization in today's society is leading to the growth of Cloud Computing IaaS In Life Science Market. Vaccine development might take up to ten years. However, owing to the advent of global knowledge sharing and cloud computing, that procedure may now be accomplished in a year by eliminating the barriers related to data location. Furthermore, cloud computing can help patients receive better treatment by allowing for a faster response to their needs.
This is accomplished by efficiently knowledge sharing by having a cloud-based platform to access data globally, which results in fewer rare cases being observed. As a result, patient recovery increases because of earlier intervention and customized treatment. One of the many benefits of cloud computing in the life science industry is the ability to minimize IT operational costs by outsourcing IT maintenance and support to the cloud provider. This allows the life science industry to reallocate resources towards key objectives such as developing new vaccines or medicines.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Cloud Computing IaaS In Life Science Market Overview
A surge in multinational and multistate clinical trials, widespread incidence of chronic diseases in major regions, and gene therapy research are driving the market for cloud computing in life sciences R&D. Drug development innovations, such as personalized medicines, necessitate the data collection and analysis from a wide range of external sources, including patients, physicians, and payers. The demand for cloud computing solutions is increasing as a result of this factor. Furthermore, the market is expected to benefit from a significant number of clinical trials conducted by various partners such as contract research organizations, academic institutions, and hospitals.
In comparison to traditional IT infrastructures, such as in-house infrastructure, cloud computing in infrastructure as a service is also much more reliable. These reasons are propelling the Cloud Computing IaaS In Life Science Market. However, significant security concerns of patient data obtained through cloud-based models, as well as a lack of proper compliance with various industry privacy regulations, have restrained the market's growth. Furthermore, the growing customization of computing solutions to meet specific needs and the rise of social media in cloud computing is expected to accelerate the adoption rate. In addition, the widespread incidence of chronic diseases in many countries has prompted companies to invest heavily in R&D to develop targeted and new therapies, opening exciting opportunities for market players.
The Global Cloud Computing IaaS In Life Science Market is Segmented on the basis of Component, Application, Deployment Model, And Geography.
Based on Component, The market is segmented into Software, Hardware, and Services. Hardware as a Service is another name for IaaS. (HaaS). It's one of the cloud computing platform's layers. Customers can outsource their IT infrastructures, such as servers, networking, processing, storage, virtual machines, and other resources, to the business. Customers access these resources on the Internet using a pay-as-per-use model.
Based on Application, The market is segmented into Nonclinical Information Systems (NCIS) and Clinical Information Systems. A non-clinical information system, often known as a hospital information system, is a computer system that manages, stores, and rechecks all medical information in hospitals, such as patient health history, prescriptions, and other special comments, all of which is stored electronically. Non-clinical systems aid decision-making and improve the efficiency and effectiveness of clinical care delivery, reducing paperwork.
Based on Deployment Model, The market is segmented into Private Cloud, Public Cloud, and Hybrid Cloud. A private cloud (also known as an internal cloud or corporate cloud) is a cloud computing environment in which all hardware and software resources are dedicated to a single customer and only that customer has access to them. Private cloud combines the elasticity, scalability, and ease of service delivery of cloud computing with the access control, security, and resource customization of on-premises infrastructure.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.